EUVIMEDEUVIMED entdecken
Crossref

Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease

Anthony Lieu iD, Alex N Zimmet iD, Joseph Pozdol, Lauren E Kushner iD, Dora Ho iD, Niaz Banaei iD

Clinical Infectious Diseases · 04.06.2025 · 80 (5) · 1095-1102

DOI: 10.1093/cid/ciaf021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 17.01.2025. Verfasst von Anthony Lieu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Invasive Fungal Infections, Cell-Free Nucleic Acids, DNA, Fungal. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mold plasma cell-free DNA (cfDNA) polymerase chain reaction (PCR) is a promising noninvasive diagnostic modality for early diagnosis of invasive mold disease (IMD) in immunocompromised patients. Although mold cfDNA PCR has been shown to be highly accurate, the value of invasive procedures to collect specimens for conventional fungal diagnostics following plasma cfDNA testing remains unclear.

Methods

This retrospective single-center cohort study included patients with mold plasma cfDNA PCR performed 7 days before or 2 days after invasive specimen collection. Mold PCR detected Aspergillus species, Mucorales agents, Fusarium species, and Scedosporium species. Invasive procedures included tissue biopsy and bronchoscopy. The primary endpoint was the concordance of mold plasma cfDNA PCR results with results of conventional fungal tests performed on tissue and bronchoalveolar lavage fluid.

Results

Five hundred and six patients with mold plasma cfDNA PCR resulting ahead of invasive specimen (123 tissue and 426 bronchoalveolar lavage fluid) results were included, and 437 (86.4%) were immunocompromised. After adjudicating discordant results based on the European Organization for Research and Treatment of Cancer and Mycoses Study Group Education and Research Consortium definitions for IMD, mold plasma cfDNA PCR and invasive test results were 88.5% (448/506) concordant. In proven cases, 64.7% (11/17) of negative mold plasma cfDNA PCR results occurred in patients with fungal sinusitis (8) and limb infection (3). Nonhematologic malignancy and nonneutropenic state were statistically associated with negative mold plasma cfDNA PCR in patients with proven or probable IMD.

Conclusions

Noninvasive mold plasma cfDNA PCR results were highly concordant with invasive specimen fungal test results, indicating risk-prone invasive specimen collection can be safely curtailed in immunocompromised patients with suspected IMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Fungal InfectionsCell-Free Nucleic AcidsDNA, FungalHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultImmunocompromised HostPolymerase Chain ReactionBronchoalveolar Lavage FluidFungiAged, 80 and overYoung Adult

Stichwörter der Autor:innen

Aspergillus PCRMucorales PCRcell-free DNAmold PCRnon-invasive testing

Substanzen

Cell-Free Nucleic AcidsDNA, Fungal

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, USA.
  • Clinical Microbiology Laboratory, Stanford Health Care, Palo Alto, California, USA.

ORCID-Profile: Anthony Lieu, Alex N Zimmet, Lauren E Kushner, Dora Ho, Niaz Banaei

Zitieren

APA

Lieu, A., Zimmet, A. N., Pozdol, J., Kushner, L. E., Ho, D., & Banaei, N. (2025). Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease. Clinical Infectious Diseases, 80(5), 1095-1102. https://doi.org/10.1093/cid/ciaf021

Vancouver

Lieu A, Zimmet AN, Pozdol J, Kushner LE, Ho D, Banaei N. Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease. Clinical Infectious Diseases. 2025;80(5):1095-1102. doi:10.1093/cid/ciaf021

BibTeX
@article{Lieu2025,
  author = {Lieu, Anthony and Zimmet, Alex N and Pozdol, Joseph and Kushner, Lauren E and Ho, Dora and Banaei, Niaz},
  title = {Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {80},
  number = {5},
  pages = {1095--1102},
  doi = {10.1093/cid/ciaf021}
}
Kostenlos starten →